Description Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide first isolated from the brain in the 1970s
For hepatic specification, the study identified a novel small-molecule cocktail, VDF (Vitamin C, Dihexa, and Forskolin), that could effectively substitute for expensive growth factors like BMPs, FGFs, and HGF
The compound remains in a regulatory gray area: recognized as safe, but without the efficacy data needed for pharmaceutical approval
Observed in infections like DENV, ADE is a potential contributor to severe disease manifestations and poses challenges for vaccine development
Researchers can explore the potential benefits of Dihexa in dementia, inflammation, and cognition with the support of existing scientific literature